A treatment that could potentially slow the progression of amyotrophic lateral sclerosis (ALS) is being studied at the Montreal Neurological Institute-Hospital. Dr. Olivier Blanchard and his team want ...
Porter, an Army Physician, had just finished 15 years of service and went into private practice when she was diagnosed with ALS, more commonly known as Lou Gehrig's disease. “Feb 18, 2021 ...
The Big Pharma has inked a deal with British biotech Alchemab Therapeutics to develop new antibodies for ALS. Under the terms of the deal, Alchemab and Lilly will work together on up to five new ...
The UK biopharma company Alchemab Therapeutics announced today that it has joined forces with Eli Lilly to discover, develop, and commercialize up to five novel therapeutics for the treatment of ...
Copyright 2025 The Associated Press. All Rights Reserved. A veteran Israeli journalist who has the degenerative disease ALS is to return to onscreen reporting thanks ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback